A Raman spectroscopy-based clinical device rapidly detects and distinguishes melanomas from benign lesions.
. Schematic of the rapid, dispersive Raman spectrometer for use in vivo skin measurements. The spectrograph uses a volume phase technology (VPT) holographic grating as the dispersing element. A back-illuminated CCD camera detects photons of different wavelengths simultaneously for rapid spectral acquisition.
detected photons of different wavelengths to obtain spectra from excised human aortic tissue with short, 5min integration times. Since then, optimized dispersive-type Raman instruments based on fiber-optic light delivery and collection, compact diode lasers, and highly efficient spectrograph-detector combinations have been reported. These advances have lead to increased sensitivity and decreased in vivo measurement time of seconds and subseconds. 4 Here, we provide an overview of our progress toward the clinical application of Raman spectroscopy for skin cancer detection.
In 2001, we constructed a clinical research prototype that was capable of obtaining Raman spectra from skin in vivo in less than 1s (see Figure 1) . 5, 6 Our instrument consisted of a stabilized diode laser (785nm), transmissive imaging spectrograph, CCD detector (NIR-optimized and back-illuminated), and a Continued on next page specially-designed Raman probe. (For rapid spectral acquisition, the spectrograph uses a volume phase technology holographic grating for high-throughput light dispersion to facilitate simultaneous whole spectrum detection by the CCD array detector.) We designed the probe to maximize the collection of Raman signals from the tissues while reducing interfering fluorescence and Raman signals from the fibers. Figure 2 shows the probe, which consists of illumination and Raman collection arms. To enhance signal detection, we packed as many fibers into the collection arm as permitted by the CCD height (6.9mm). The fiber bundle consisted of 58 fibers (each 100 m in diameter) arranged in a circle at the input end and a linear array at the output end, which is connected to the spectrograph. We arranged the fibers of the linear array along a parabolic curve to correct for spectrograph image aberration (see Figure 3 ). This also allowed hardware binning of the vertical spectral line on the CCD. Hardware binning is the capability of the CCD to accumulate electrons from different pixels in one vertical column (i.e., channel) that correspond to the same photon wavelength. We found this preserved spectral resolution and yielded a 16-fold improvement in the signal to noise ratio. Using our system, a spectrum can be acquired within 1s, a vast improvement compared to 20-90s acquisition time for other systems at the time.
More recently, we developed and tested an endoscopic Raman probe for real-time in vivo lung cancer detection. [7] [8] [9] To achieve this, we miniaturized the probe to 1.8mm in diameter, which is small enough to pass through a bronchoscope instrument channel. We placed one excitation fiber in the center of the catheter with 27 collection fibers surrounding it. To obtain high quality measurements, we used first-order optical filtering at the distal tip of the catheter and second stage, and high-performance filtering immediately after the catheter emerges from the bronchoscope channel. Standard filters can be used in the second stage filtering, but we directly coated the first-stage filters onto the fiber end face. We collected enough signal to acquire Raman spectra within 2s.
To process raw spectral data-including Raman signals superimposed on strong fluorescence background signals-we developed a unique polynomial-fitting algorithm to remove background fluorescence. 10 Our algorithm facilitated real-time data processing during in vivo Raman measurements. 11 Our algorithm is freely available to academic users online. 12 Building on this progress, we analyzed data from 274 skin lesions including cancers (31 melanomas, 18 basal cell carcinomas, and 39 squamous cell carcinomas), precancerous lesions (20 actinic keratoses), and benign lesions (48 seborrheic keratoses and 118 various nevi). Rather than following specific molecules in skin and individual peaks of the Raman spectra, we analyzed changes in the overall spectral shape. Our results showed that, Continued on next page by using Raman spectroscopy, precancerous lesions and cancerous lesions can be differentiated from benign lesions with a sensitivity of 90% and specificity of 75%. Additionally, melanomas are differentiated from other pigmented lesions with nearly 100% sensitivity and 70% specificity. 4 This is very encouraging for introducing Raman spectroscopy to clinical use. We have acquired in vivo Raman data from approximately 1000 skin lesions and are currently analyzing the data to develop an optimized algorithm for melanoma detection.
In summary, we have developed a sensitive, Raman instrument for rapid in vivo measurement. We are currently collaborating with Verisante Technology, Inc. to develop our Raman system into a more compact, robust, and cost-effective clinical device. We are also expanding the applications of our Raman technology beyond dermal and pulmonary tissues sites. Harvey Lui is professor and chairman of the Department of Dermatology and Skin Science. He is a clinical dermatologist with over 90 publications whose research interests include photomedicine, lasers, photodynamic therapy, pigmentary disorders, and optical diagnosis. He is a former co-chair of the SPIE Dermatology and Plastic Surgery conference.
David McLean is a professor in the Department of Dermatology and Skin Science and head of the British Columbia Cancer Agency Prevention Programs. He has published over 80 papers and has seven issued patents. His research focuses on the machine diagnosis of skin cancers.
